Geron CorpGERN
Price$1.21Intrinsic value$1.221% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $183.9M+138.8% YoYTTM through 31 Dec 2025
Net Income -$85.8MTTM through 31 Dec 2025
Free Cash Flow -$111.1MTTM through 31 Dec 2025

Margins

Current
Gross Margin97.4%
Operating Margin-38.5%
Net Margin-46.7%

Returns

-37.5%ROE
-15.0%ROA

Balance Sheet Health

Debt / Equity1.10x
Current Ratio4.70x
Net Debt-$108Mnet cash position
Cash & Equivalents$79.4M

Quality Metrics

FCF Margin-60.4%
Rule of 40-31.9
Earnings-Beat Rate100.0%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
RYTELO Product Sales$183.6M+140.0%
View details

Management expects RYTELO net product revenue to be in the range of $220 million to $240 million for fiscal year 2026.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.